Trend Innovations engages Percy Kwong as Technology Advisor with quarterly stock compensation up to $250K

AVAI BIO, INC.

Advisor receives $150K/quarter in common stock (85% of 10-day VWAP, floor $0.10/share) for tech advisory services.
If stock lists on Nasdaq, quarterly fee rises to $250K retroactive to April 15, 2023; term ends May 5, 2024 with possible renewal.
Shares are unregistered; advisor is an accredited investor and bears own taxes; indemnification and insurance required from company.
Advisor retains ownership of independent inventions and may continue work for other companies; agreement terminates for convenience.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.